---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-033578"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2026-02-02T23:59:59+00:00"
generated_at: "2026-05-16T05:37:08.720790+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte raises $600.2M in public offering of 12.65M shares at $50/share

## Summary
- Offering of 11M shares at $50.00 public price; underwriter option for 1.65M shares exercised.
- Net proceeds of approximately $600.2M after underwriting discounts and expenses.
- Underwriters purchased shares at $47.50 each; offering closed on February 2, 2026.
- Proceeds will support general corporate purposes, including pipeline development.

## SEC filing metadata
- accession: 0001193125-26-033578
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2026-02-02T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000119312526033578/0001193125-26-033578-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000119312526033578/d54534d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-033578
- JSON: https://secwatch.observer/filing/0001193125-26-033578.json
- Plain text: https://secwatch.observer/filing/0001193125-26-033578.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.